Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil.
BACKGROUND
Previous studies have shown that acute intake of high-phenol virgin olive oil reduces pro-inflammatory, pro-oxidant and pro-thrombotic markers compared with low phenols virgin olive oil, but it still remains unclear whether effects attributed to its phenolic fraction are exerted at transcriptional level in vivo. To achieve this goal, we aimed at identifying expression changes in genes which could be mediated by virgin olive oil phenol compounds in the human.


RESULTS
Postprandial gene expression microarray analysis was performed on peripheral blood mononuclear cells during postprandial period. Two virgin olive oil-based breakfasts with high (398 ppm) and low (70 ppm) content of phenolic compounds were administered to 20 patients suffering from metabolic syndrome following a double-blinded, randomized, crossover design. To eliminate the potential effect that might exist in their usual dietary habits, all subjects followed a similar low-fat, carbohydrate rich diet during the study period. Microarray analysis identified 98 differentially expressed genes (79 underexpressed and 19 overexpressed) when comparing the intake of phenol-rich olive oil with low-phenol olive oil. Many of these genes seem linked to obesity, dyslipemia and type 2 diabetes mellitus. Among these, several genes seem involved in inflammatory processes mediated by transcription factor NF-kappaB, activator protein-1 transcription factor complex AP-1, cytokines, mitogen-activated protein kinases MAPKs or arachidonic acid pathways.


CONCLUSIONS
This study shows that intake of virgin olive oil based breakfast, which is rich in phenol compounds is able to repress in vivo expression of several pro-inflammatory genes, thereby switching activity of peripheral blood mononuclear cells to a less deleterious inflammatory profile. These results provide at least a partial molecular basis for reduced risk of cardiovascular disease observed in Mediterranean countries, where virgin olive oil represents a main source of dietary fat. Admittedly, other lifestyle factors are also likely to contribute to lowered risk of cardiovascular disease in this region.
Camargo
Antonio
A
IMIBIC (Instituto Maimonides de Investigacion Biomedica de Cordoba), Reina Sofia University Hospital, University of Cordoba, Spain.
Ruano
Juan
J
Fernandez
Juan M
JM
Parnell
Laurence D
LD
Jimenez
Anabel
A
Santos-Gonzalez
Monica
M
Marin
Carmen
C
Perez-Martinez
Pablo
P
Uceda
Marino
M
Lopez-Miranda
Jose
J
Perez-Jimenez
Francisco
F
D004041:Dietary Fats / Q000627:therapeutic use*; D020869:Gene Expression Profiling; D053263:Gene Regulatory Networks; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000737:chemistry / Q000378:metabolism*; D053858:Metabolic Networks and Pathways; D024821:Metabolic Syndrome / Q000178:diet therapy* / Q000235:genetics* / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D000069463:Olive Oil; D010636:Phenols / Q000032:analysis; D010938:Plant Oils / Q000737:chemistry / Q000627:therapeutic use*; D019518:Postprandial Period
D004041:Dietary Fats; D000069463:Olive Oil; D010636:Phenols; D010938:Plant Oils
Am J Clin Nutr. 2009 Jan;89(1):248-56
19056596
Circulation. 2003 Jan 28;107(3):391-7
12551861
J Nutr. 2004 May;134(5):1039-44
15113942
Metabolism. 2008 Feb;57(2):192-9
18191048
JAMA. 2004 Sep 22;292(12):1440-6
15383514
OMICS. 2009 Feb;13(1):7-19
19290808
Mol Genet Metab. 2007 Apr;90(4):422-8
17123852
J Cell Biochem. 2009 Mar 1;106(4):729-37
19173302
Am J Clin Nutr. 2007 Aug;86(2):341-6
17684203
Endocrinology. 2004 Dec;145(12):5847-61
15331573
J Nutr. 2005 Oct;135(10):2291-4
16177184
Nutr Rev. 2005 Sep;63(9):312-4
16220642
J Nutr. 2008 Jun;138(6):1074-8
18492836
Nature. 2005 Oct 13;437(7061):1032-7
16136080
J Biochem. 2006 Sep;140(3):383-91
16873395
Clin Sci (Lond). 2009 Feb;116(3):241-8
18643775
Am J Clin Nutr. 2004 Dec;80(6):1487-91
15585759
J Lipid Res. 2008 Sep;49(9):1894-903
18503031
Arthritis Res Ther. 2008;10(1):201
18226189
J Immunol. 2006 Dec 1;177(11):7497-504
17114416
Ann Clin Biochem. 1981 May;18(Pt 3):177-81
7283369
J Am Coll Cardiol. 1994 Nov 15;24(6):1468-74
7930277
Nature. 2008 Mar 27;452(7186):429-35
18344982
J Am Coll Cardiol. 2005 Nov 15;46(10):1864-8
16286173
J Clin Endocrinol Metab. 2006 Jan;91(1):295-9
16234302
Circulation. 2004 Sep 21;110(12):1564-71
15364812
Nutrition. 2009 May;25(5):548-54
19195840
Atherosclerosis. 2007 Jan;190(1):181-6
16488419
Curr Atheroscler Rep. 2001 Nov;3(6):462-70
11602066
Eur J Clin Invest. 2005 Jul;35(7):421-4
16008542
Clin Chem. 1972 Jun;18(6):499-502
4337382
Circulation. 2002 Feb 19;105(7):804-9
11854119
Clin Chem. 1973 May;19(5):476-82
4703655
Naunyn Schmiedebergs Arch Pharmacol. 2009 Jun;379(6):581-6
19198806
Ann Intern Med. 2006 Sep 5;145(5):333-41
16954359
Blood. 2007 May 1;109(9):3998-4005
17227832
J Nutr. 2003 Nov;133(11 Suppl 1):3805S-3810S
14608118
Curr Opin Clin Nutr Metab Care. 2007 Nov;10(6):724-8
18089954
Clin Chem. 1974 Apr;20(4):470-5
4818200
Curr Opin Lipidol. 2009 Feb;20(1):39-44
19133410
J Biol Chem. 2009 Feb 13;284(7):4073-89
19088076
Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):13-23
15871846
Atherosclerosis. 2007 Oct;194(2):e141-6
17204269
Curr Opin Cardiol. 2006 May;21(3):185-93
16601455
Atherosclerosis. 2004 Nov;177(1):175-82
15488881
Circulation. 2005 Apr 19;111(15):1938-45
15837947
J Clin Endocrinol Metab. 2007 Sep;92(9):3705-11
17595242
Circulation. 2009 Mar 10;119(9):1284-92
19237660
Br J Nutr. 2007 Apr;97(4):628-38
17349074
Nat Rev Drug Discov. 2003 Nov;2(11):879-90
14668809
Mol Nutr Food Res. 2007 Oct;51(10):1199-208
17879991